Mezzasalma Advisors’s Exelixis EXEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.2M Sell
22,095
-1,608
-7% -$78.3K 0.24% 61
2026
Q1
$1.02M Sell
23,703
-48,041
-67% -$2.07M 0.26% 56
2025
Q4
$3.13M Buy
71,744
+7,803
+12% +$323K 0.75% 35
2025
Q3
$2.64M Buy
63,941
+7,470
+13% +$300K 0.68% 37
2025
Q2
$2.49M Buy
56,471
+5,817
+11% +$233K 0.75% 34
2025
Q1
$1.87M Buy
+50,654
New +$1.8M 0.65% 32

Other funds holding EXEL

Mezzasalma Advisors's EXEL Position: Q2 2026 in Review

Mezzasalma Advisors reduced its Exelixis (EXEL) stake by 6.8% in Q2 2026, selling an estimated $78.3K and leaving 22,095 shares worth $1.2M. The position accounts for 0.24% of the portfolio, ranked #61.

Mezzasalma Advisors first reported a position in EXEL in Q1 2025 and has held it in 6 quarters since. The position peaked at $3.13M in Q4 2025. 758 funds tracked by Wall St. Rank hold EXEL as of Q2 2026.

  • Mezzasalma Advisors held 22,095 shares of Exelixis worth $1.2M as of Q2 2026.
  • Mezzasalma Advisors sold 1,608 Exelixis shares in Q2 2026, an estimated $78.3K.
  • Exelixis made up 0.24% of Mezzasalma Advisors's portfolio in Q2 2026, its #61 holding.
  • Mezzasalma Advisors first reported a position in Exelixis in Q1 2025 and has held it in 6 quarters since.
  • Mezzasalma Advisors's Exelixis position peaked at $3.13M in Q4 2025.
  • 758 funds tracked by Wall St. Rank held Exelixis as of Q2 2026.

Based on Mezzasalma Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.